compound 12k [PMID: 31676236]   Click here for help

GtoPdb Ligand ID: 13267

Synonyms: Prosetin | Prostetin [1]
Compound class: Synthetic organic
Comment: Compound 12k (prostetin/prosetin) is an oral, brain-penetrant MAP4 kinase inhibitor that exhibits a protective effect for motor neurons [1]. Functionally it reduces ER stress-mediated neurodegeneration as an outcome of the misfolded protein response in ALS neurons. It also has anti-inflammatory properties.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 2
Rotatable bonds 6
Topological polar surface area 51.1
Molecular weight 446.97
XLogP 1.5
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C1=CC(=CC(=C1)Cl)C2=CNC3=C2C=C(C=N3)C4=CC=C(C=C4)CN5CCN(CC5)CCO
Isomeric SMILES OCCN1CCN(CC2=CC=C(C=C2)C3=CC4=C(NC=C4C5=CC=CC(Cl)=C5)N=C3)CC1
InChI InChI=1S/C26H27ClN4O/c27-23-3-1-2-21(14-23)25-17-29-26-24(25)15-22(16-28-26)20-6-4-19(5-7-20)18-31-10-8-30(9-11-31)12-13-32/h1-7,14-17,32H,8-13,18H2,(H,28,29)
InChI Key VZJUKEQMHBEIKH-UHFFFAOYSA-N
No information available.
Summary of Clinical Use Click here for help
ProJenX are developing this agent (known as prosetin) as a novel treatment for amyotrophic lateral sclerosis (ALS) The FDA designated this compound as an orphan drug for ALS in April 2020.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT05279755 A Study to Evaluate the Safety and Pharmacokinetics of Single and Multiple Doses of Prosetin in Healthy Volunteers Phase 1 Interventional ProJenX The PRO-101 study.